Items where Author is "Cross, Neil"
Number of items: 29.
Article
LITTLE, Liam David, BARNETT, Sarah E, ISSITT, Theo, BONSALL, Sam, CAROLAN, Vikki, ALLEN, Elizabeth, COLE, Laura, CROSS, Neil, COULSON, Judy M and HAYWOOD-SMALL, Sarah
(2024).
Volatile Organic Compound Analysis of Malignant Pleural Mesothelioma Chorioallantoic Membrane Xenografts.
Journal of breath research, 18 (4): 046010.
[Article]
MAHBUB, Amani A., LE MAITRE, Christine, CROSS, Neil and JORDAN-MAHY, Nicola
(2022).
The effect of apigenin and chemotherapy combination treatments on apoptosis-related genes and proteins in acute leukaemia cell lines.
Scientific Reports, 12 (1): 8858.
[Article]
KNOWLES, Alex, CAMPBELL, Susan, CROSS, Neil and STAFFORD, Prachi
(2021).
Bacterial manipulation of the Integrated Stress Response: a new perspective on infection.
Frontiers in Microbiology, 12.
[Article]
SPENCER, Chloe E., FLINT, L.E., DUCKETT, Catherine, COLE, Laura, CROSS, Neil, SMITH, David and CLENCH, Malcolm
(2021).
Role of MALDI-MSI in combination with 3D tissue models for early stage efficacy and safety testing of drugs and toxicants.
Expert Review of Proteomics, 17 (11-12), 827-841.
[Article]
HUDSON, Katie, CROSS, Neil, JORDAN-MAHY, Nikki and LEYLAND, Rebecca
(2020).
The Extrinsic and Intrinsic Roles of PD-L1 and Its Receptor PD-1: Implications for Immunotherapy Treatment.
Frontiers in Immunology, 11, p. 568931.
[Article]
PHILLIPS, Kate, WRIGHT, Nicola, MCDERMOTT, E. and CROSS, Neil
(2019).
TRAIL responses are enhanced by nuclear export inhibition in osteosarcoma.
Biochemical and Biophysical Research Communications, 517 (2), 383-389.
[Article]
MAHBUB, Amani A., LE MAITRE, Christine, HAYWOOD-SMALL, Sarah, CROSS, Neil and JORDAN-MAHY, Nikki
(2019).
Polyphenols enhance the activity of alkylating agents in leukaemia cell lines.
Oncotarget, 10 (44).
[Article]
LALWANI, Nikhil, ALLEN, David, HORTON, Peter N, COLES, Simon J, CROSS, Neil and BRICKLEBANK, Neil
(2019).
Methoxy-phenyl groups reduce the cytotoxicity and increase the aqueous solubility of phosphonium zwitterions and salts.
Polyhedron, 158, 515-523.
[Article]
DOHERTY, Rachel E., SISLEY, Karen, HAMMOND, David W., RENNIE, Ian G. and CROSS, Neil
(2017).
Phenotypic Plasticity in Uveal Melanoma Is Not Restricted to a Tumor Subpopulation and Is Unrelated to Cancer Stem Cell Characteristics.
Investigative Opthalmology & Visual Science, 58 (12), p. 5387.
[Article]
ARHOMA, A., CHANTRY, A. D., HAYWOOD-SMALL, Sarah and CROSS, Neil
(2017).
SAHA-induced TRAIL-sensitisation of Multiple Myeloma cells is enhanced in 3D cell culture.
Experimental cell research.
[Article]
MAHBUB, Amani, LE MAITRE, Christine, HAYWOOD-SMALL, Sarah, CROSS, Neil and JORDAN-MAHY, Nikki
(2017).
Dietary polyphenols influence antimetabolite agents: methotrexate, 6-mercaptopurine and 5-fluorouracil in leukemia cell lines.
Oncotarget, 8 (62), 104877-104893.
[Article]
HARVEY, Amanda, DAY, Rebecca, COLE, Laura M., BARTLETT, Maggie, WARWICK, John, BOJAR, Richard, SMITH, David, CROSS, Neil and CLENCH, Malcolm R.
(2016).
MALDI-MSI for the analysis of a 3D tissue-engineered psoriatic skin model.
Proteomics, 16 (11-12), 1718-1725.
[Article]
ZAINI, R, HAYWOOD-SMALL, S, CROSS, Neil and LE MAITRE, Christine
(2015).
Differential interactions of Falcarinol combined with anti-tumour agents on cellular proliferation and apoptosis in human lymphoid leukaemia cell lines.
Journal of Blood Disorders and Transfusion, 6 (2).
[Article]
LALWANI, Nikhil, CHEN, Yu-Su, CROSS, Neil, BROOKE, Gemma, ALLEN, David W., REYNOLDS, Alan, OJEDA, Jesús, TIZZARD, Graham J., COLES, Simon J. and BRICKLEBANK, Neil
(2015).
Triphenylarsonium-functionalised gold nanoparticles : potential nanocarriers for intracellular therapeutics.
Chemical Communications, 51 (19), 4109-4111.
[Article]
MAHBUB, Amani A, LE MAITRE, Christine, HAYWOOD-SMALL, Sarah, MCDOUGALL, Gordon J, CROSS, Neil and JORDAN-MAHY, N.
(2013).
Differential effects of polyphenols on proliferation and apoptosis in human myeloid and lymphoid leukemia cell lines.
Anti-cancer agents in medicinal chemistry, 13 (10), 1601-1613.
[Article]
SINGH MUDHAR, Hardeep S., SCOTT, Ian, UL-HASSAN, Aliya, BURTON, David, DOHERTY, Rachel, CROSS, Neil, RENNIE, Ian G. and SISLEY, Karen
(2012).
Bilateral diffuse uveal melanocytic hyperplasia (BDUMP)-molecular characterisation and novel association with bilateral renal papillary carcinoma.
Histopathology, 61 (4), 751-754.
[Article]
HSU, Y P, STATON, C A, CROSS, Neil and BUTTLE, D J
(2012).
Anti-angiogenic properties of ADAMTS-4 in vitro.
International Journal Of Experimental Pathology, 93 (1), 70-77.
[Article]
DOHERTY, R.E., HAYWOOD-SMALL, Sarah, SISLEY, K. and CROSS, Neil
(2011).
Aldehyde dehydrogenase activity selects for the holoclone phenotype in prostate cancer cells.
Biochemical and Biophysical Research Communications, 414 (4), 801-807.
[Article]
SISLEY, K, DOHERTY, R and CROSS, Neil
(2011).
What hope for the future? GNAQ and uveal melanoma.
British Journal of Ophthalmology, 95 (5), 620-623.
[Article]
NYAMBO, Rachel, CROSS, Neil, LIPPITT, Jenny, HOLEN, Ingunn, BRYDEN, Gorden, HAMDY, Freddie C and EATON, Colby L
(2004).
Human bone marrow stromal cells protect prostate cancer cells from TRAIL-induced apoptosis.
Journal of Bone and Mineral Research (JBMR), 19 (10), 1712-1721.
[Article]
DIZEYI, N, BJARTELL, A, NILSSON, E, HANSSON, J, GADALEANU, V, CROSS, Neil and ABRAHAMSSON, P-A
(2004).
Expression of serotonin receptors and role of serotonin in human prostate cancer tissue and cell lines.
The Prostate, 59 (3), 328-336.
[Article]
WOODWARD, Julia K L, ELSHAW, Shona R, MURRAY, Anna K, NICHOLS, Carmel E, CROSS, Neil, LAWS, David, RENNIE, Ian G and SISLEY, Karen
(2002).
Stimulation and inhibition of uveal melanoma invasion by HGF, GRO, IL-1alpha and TGF-beta.
Investigative ophthalmology & visual science, 43 (10), 3144-3152.
[Article]
Pre-print
ALZUFAIRI, A.A., SOUILHOL, C., JORDAN-MAHY, Nikki and CROSS, Neil
(2023).
Assessment of ferroptosis inducers and Nrf2 inhibitors as radiosensitisers in 2D and 3D breast cancer cell cultures.
[Pre-print]
(Unpublished)
[Pre-print]
Conference or Workshop Item
HUDSON, Katie, CROSS, Neil, JORDAN-MAHY, Nicola and LEYLAND, Rebecca
(2021).
Investigating the tumour-intrinsic role of programmed death-ligand 1 in 2D and 3D cell culture models of human breast cancer.
In: British Society for Immunology Congress 2021, Edinburgh, UK, 28 Nov - 01 Dec 2021.
(Unpublished)
[Conference or Workshop Item]
HUDSON, Katie, CROSS, Neil, JORDAN-MAHY, Nicola and LEYLAND, Rebecca
(2020).
Blockade of Programmed Death-Ligand 1 with Atezolizumab in Human Breast Cancer 3D Spheroid Colonies Induces Changes in Cell Viability.
In: EACR-AACR-ASPIC Conference: Tumour Microenvironment, Lisbon, Portugal, 02-04 Mar 2020.
European Association for Cancer Research.
(Unpublished)
[Conference or Workshop Item]
HUDSON, Katie, JORDAN-MAHY, Nikki, CROSS, Neil and LEYLAND, Rebecca
(2019).
Programmed death-ligand 1 expression in human cancer cell lines in two-dimensional and three-dimensional cell culture systems.
In: BACR: Tumour Microenvironment meeting, Nottingham, UK, 01-03 Jul 2019.
British Association for Cancer Research.
(Unpublished)
[Conference or Workshop Item]
STOKES, Hannah, CROSS, Neil and LEYLAND, Rebecca
(2018).
Characterisation of novel lung cancer cell lines for immuno-inhibitory markers.
In: BMRC/MERI Winter Poster Event 2018, Sheffield, 14 Dec 2018.
BMRC/MERI.
(Unpublished)
[Conference or Workshop Item]
HUDSON, Katie, CROSS, Neil, JORDAN-MAHY, Nicola and LEYLAND, Rebecca
(2018).
Flow cytometric phenotyping of diverse human cancer cell lines for immunological biomarkers expression.
In: BMRC/MERI Winter Poster Event, Sheffield, 14 Dec 2018.
BMRC/MERI.
(Unpublished)
[Conference or Workshop Item]
DOWLING, Joshua, FERRIERA DE MATOS, Cristiana, LEYLAND, Rebecca and CROSS, Neil
(2018).
Investigation of TRAIL resistance in lung cancer cell lines.
In: British Society for Immunology: Yorkshire Immunology Group Symposium 2018, University of York, UK, 15th June 2018.
(Unpublished)
[Conference or Workshop Item]